港股異動 | 醫療板塊再度走強 永勝醫療(1612.HK)漲超14%
格隆匯5月3日丨港股醫療板塊再度走強,永勝醫療(1612.HK)漲14.7%,春立醫療(1858.HK)、愛康醫療(1789.HK)漲超7%。日前,工業和信息化部、國家衞生健康委聯合召開推進醫療裝備發展應用領導小組工作會議,工業和信息化部副部長辛國斌強調,下一步要聚焦臨牀需求和健康保障,持續發力、久久為功,推進製造強國、健康中國建設。推動強鏈補鏈,提升產業基礎能力和產業鏈現代化水平;推動醫療裝備產業和衞生健康事業高質量發展。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.